Centanafadine XR demonstrated efficacy in improving symptoms in adults with attention-deficit/hyperactivity disorder and comorbid anxiety.

Federal authorities convicted a telehealth company founder and clinical president for illegal stimulant prescription ...

The FDA has approved Simtriyo (centanafadine), a first-in-class NDSRI and CNS stimulant, for adult and pediatric ADHD aged 6 years and older.

Children and adolescents appear to experience a greater level of psychological burden in association with atopic dermatitis.

Depressive symptoms were consistently associated with a greater tendency for social media likes to reinforce subsequent posting frequency, underscoring the need to integrate in-laboratory and ...

Some doctors are concerned about the accessibility of poorly labeled THC-based beverages, while others see a potential alcohol alternative.

Almost 25% of workers in the US report staying in a job they do not want in order to maintain health care coverage.

Adolescent non-suicidal self-injury functions as part of a complex, interconnected symptom-risk system rather than as an isolated behavior.

Patients and physiotherapists weigh physical and psychosocial factors differently when assessing recovery from chronic low back pain.

An outside advisory panel to the FDA is pushing for the production and sale of a few previously banned peptide treatments.

Task-sharing mental health care with non-specialist providers benefits adults with psychologic distress after experiencing violence.

Shared genetic architecture may explain the co-occurrence of psychiatric disorders and metabolic abnormalities such as insulin resistance.